Anti-diabetic effect of trigonelline and nicotinic acid, on KK-Ay mice

Current Medicinal Chemistry

Volumn 17, Issue 20, 2010, Pages 2196-2202

  Yoshinari, O ^a   Igarashi, K ^b  

^a IWATE UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Insulin resistance; Nicotinic acid; TNF ; Trigonelline

Indexed keywords

GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; HEMOGLOBIN A1C; INSULIN; NICOTINIC ACID; TRIACYLGLYCEROL; TRIGONELLINE; TUMOR NECROSIS FACTOR ALPHA; ALKALOID; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; DRUG EFFICACY; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; LIVER; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; ORGAN WEIGHT; TREATMENT OUTCOME; ANALYSIS; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, TYPE 2; METABOLISM; MOUSE MUTANT; RAT;

ALKALOIDS; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; GLUCOKINASE; GLUCOSE-6-PHOSPHATASE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; MICE, OBESE; NIACIN; RATS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955624213     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791299902     Document Type: Article

References (25)

1. Rosca, M.G.; Mustata, T.G.; Kinter, M.T.; Ozdemir, A.M.; Kern, T.S.; Szweda, L.I.; Brownlee, M.; Monnier, V.M.; Weiss, M.F. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am. J. Physiol. Renal Physiol., 2005, 289, 420-430.
2. Obrosova, I.G. Update on the pathogenesis of diabetic neuropathy. Curr. Diab. Rep., 2003, 3, 439-445.
3. Brands, M.W.; Lee, W.F.; Keen, H.L.; Alonso-Galicia, M.; Zappe, D.H.; Hall, J.E. Cardiac output and renal function during insulin hypertension 1 in Sprague-Dawley rats. Am. J. Physiol., 1996, 271, 276-281.
4. Yoshinari, O.; Sato, H.; Igarashi, K. Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on gotokakizaki rats. Biosci. Biotechnol. Biochem., 2009, 73, 1033-1041
5. Goto, Y.; Suzuki, K.; Ono, T.; Sasaki, M.; Toyota, T. Development of diabetes in the non-obese NIDDM rat (GK rat). Adv. Exp. Med. Biol., 1988, 246, 29-31.
6. Vogt, A.; Kassner, U.; Hostalek, U.; Steinhagen-Thiessen, E. Prolonged- release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study. Vasc. Health Risk Manag., 2007, 3, 467-479.
7. Guyton, J.R. Niacin in cardiovascular prevention: mechanisms, efficacy, and safety. Curr. Opin. Lipidol., 2007, 18, 415-420.
8. Chang, A.Y.; Wyse, B. M.; Copeland, E. J.; Peterson, T.; Ledbetter, S. R. In Diabetes, Ed.; Elsevier Science B. V: Amsterdam, 1986; pp. 466-470.
9. Herberg, L.; Coleman, D.L. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism, 1977, 26, 59-99.
10. Tang, Y.; Osawa, H.; Onuma, H.; Nishimiya, T.; Ochi, M.; Makino, H. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice. Diabetes, 1999, 48, 1830-1835
11. Friedewald, W.T.; Levy, R.I.; Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 1972 18, 499-502.
12. Reaven, G.D. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr., 2005, 25, 391-406.
13. Hotamisligil, G.S.; Shargill, N.S.; Spiegelman, B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesitylinked insulin resistance. 1 Science, 1993, 259, 87-91.
14. Taniguchi, C.M.; Emanuelli, B.; Kahn, C.R. Critical nodes in signaling pathways: insights into insulin-Action. Nat. Rev. Mol. Cell Biol., 2006, 7, 85-96.
15. Hotamisligil, G.S.; Arner, P.; Caro, J.F. Increased adipose tissue expression of tumar necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest., 1995, 95, 2409-2415.
16. Okuno, A.; Tamemoto, H.; Tobe, K.; Ueki, K.; Mori, Y.; Iwamoto, K.; Umesono, K.; Akanuma, Y.; Fujiwara, T.; Horikoshi, H.; Yazaki, Y.; Kadowaki, T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest., 1998, 101, 1354-1361.
17. Suganami, T.; Nishida, J.; Ogawa, Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 2062-2068.
18. Karpe, F.; Frayn, K.N. The nicotinic acid receptor-a new mechanism for an old drug. Lancet, 2004, 363, 1892-1894.
19. McCulloch, D.K.; Kahn, S.E.; Schwartz, M.W.; Koerker, D.J.; Palmer, J.P. Effect of nicotinic acid induced insulin resistance on pancreatic B cell function in normal and streptozocin-treated baboons. J. Clin. Invest., 1991, 87, 1395-1401.
20. Ar'Rajab, A.; Ahrén, B. Effects of yohimbine and nicotinic acid on insulin secretion in islet transplanted streptozotocin-diabetic rats. Diabetes Res. Clin. Pract., 1991, 11, 81-87.
21. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest., 2004, 114, 1752-1761.
22. Mason, B.J.B.; Kodicek, E. The metabolism of niacytin in the rat: studies of the excretion of nicotinic acid metabolites. 1 Biochem. J., 1970, 120, 509-513.
23. Mason, B.J.B.; Kodicek, E. The metabolism of niacytin in the rat: trigonelline as a major metabolite of niacytin in the urine. Biochem. J., 1970, 120, 515-521.
24. Sandhu, J.S.; Fraser, DR. The metabolic origin of trigonelline in the rat. Biochem. J. 1981, 200, 495-500.
25. Yuyama, S.; Suzuki, T. Isolation and identification of N1- methylnicotinic acid (trigonelline) from rat urine. J. Nutr. Sci. Vitaminol. 1985, 31, 157-167.